These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
397 related items for PubMed ID: 12850243
1. ATP-dependent potassium channels involved in the cardiac protection induced by intermittent hypoxia against ischemia/reperfusion injury. Zhu HF, Dong JW, Zhu WZ, Ding HL, Zhou ZN. Life Sci; 2003 Jul 25; 73(10):1275-87. PubMed ID: 12850243 [Abstract] [Full Text] [Related]
9. KR-31762, a novel KATP channel opener, exerts cardioprotective effects by opening SarcKATP channels in rat models of ischemia/reperfusion-induced heart injury. Lee SH, Yang MK, Lim JH, Seo HW, Yi KY, Yoo SE, Lee BH, Won HS, Lee CS, Choi WS, Shin HS. Arch Pharm Res; 2008 Apr 25; 31(4):482-9. PubMed ID: 18449506 [Abstract] [Full Text] [Related]
10. Effects of cromakalim and glibenclamide on myocardial high energy phosphates and intracellular pH during ischemia-reperfusion: 31P NMR studies. Docherty JC, Gunter HE, Kuzio B, Shoemaker L, Yang L, Deslauriers R. J Mol Cell Cardiol; 1997 Jun 25; 29(6):1665-73. PubMed ID: 9220352 [Abstract] [Full Text] [Related]
13. The KATP blocker sodium 5-hydroxydecanoate does not abolish preconditioning in isolated rat hearts. Grover GJ, Murray HN, Baird AJ, Dzwonczyk S. Eur J Pharmacol; 1995 Apr 24; 277(2-3):271-4. PubMed ID: 7493619 [Abstract] [Full Text] [Related]
14. Role of an ATP-sensitive potassium channel opener, YM934, in mitochondrial energy production in ischemic/reperfused heart. Tanonaka K, Taguchi T, Koshimizu M, Ando T, Morinaka T, Yogo T, Konishi F, Takeo S. J Pharmacol Exp Ther; 1999 Nov 24; 291(2):710-6. PubMed ID: 10525091 [Abstract] [Full Text] [Related]